Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
A quick recap of 'Stranger Things' Seasons 1-4, plus key episodes to rewatch before Volume 1 of the final season drops - 2Go With The Breeze: Grand Paragliding Spots On the planet
- 3Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- 4UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
- 5A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue
- How a Snake That Eats Cobras Redefined the Meaning of ‘King’
- Ocean side Objections: Staggering Waterfront Breaks
- UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
- Humpback whale stranded on Germany's Baltic coast frees itself
- Rick Steves Doesn't Want You Overlooking This Food Spot While In France
- Former biotech CEO sued over COVID vaccine alleged insider trading
- The Most Astonishing Arising Advancements to Watch
- Famous Places to get-away for Americans
- German-Polish man charged with calling for attacks on top politicians
